Why does iron chelation therapy worsen outcomes in H63D HFE variant carriers despite reducing iron levels?
Analysis ID: SDA-2026-04-15-gap-pubmed-20260411-092119-691e1977 | Domain: neurodegeneration | Status: failed | Created: 2026-04-15T10:26:18.727264
Knowledge Graph: 2 edges — View JSON
Top Hypotheses (2 total)
#1 REDD1-mTOR Axis as the Master Regulator — Preservation Over Chelation
0.586
DDIT4 (REDD1), MTOR
# REDD1-mTOR Axis as the Master Regulator of H63D-Mediated Neuroprotection: Preservation Over Chelation
## The Central Hypothesis
The H63D variant of the HFE gene has long presented a paradox in neu
#2 ER Stress Reduction as Adjunctive Therapy to Support Autophagy
0.566
HFE (H63D variant)
H63D HFE causes prolonged endoplasmic reticulum stress (PMID:21349849), which paradoxically triggers the REDD1-autophagy axis as a compensatory protective mechanism. Iron chelation may exacerbate ER s